Such therapeutic targets in sarcomas include T cell Immunoglobulin and Mucin-domain containing-3 (TIM-3), Leukocyte Activation Gene-3 (LAG-3), and T cell Immunoreceptor with Ig and ITIM domains (TIGIT). The gene discussed is LAG3; the disease is sarcoma.